• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background

    Gangrene Companies

    ID: MRFR/Pharma/1343-HCR
    90 Pages
    Rahul Gotadki
    October 2025

    Gangrene companies specialize in providing medical solutions for the treatment and management of gangrene, a condition characterized by the death of body tissue due to lack of blood supply. These companies contribute to wound care, vascular surgery, and infectious disease management by offering interventions, surgical options, and medications to address and prevent gangrenous tissue.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Top Industry Leaders in the Gangrene Market

    Gangrene companies

     


    Latest Gangrene Companies Updates:


    Convatec Developed a new hydrogel dressing with enhanced moisture management and antimicrobial properties for promoting healing in gangrene wounds.


    Mölnlycke Health Care Announced the expansion of its negative pressure wound therapy (NPWT) system portfolio with options specifically designed for gangrene management.


    Medtronic Received FDA approval for its advanced debridement tool that combines suction and irrigation for effective removal of necrotic tissue in gangrene wounds.


    Smith & Nephew Partnered with a biopharmaceutical company to develop a novel topical antibiotic gel with potential to combat antibiotic-resistant bacteria commonly found in gangrene infections.


    AngioDynamics Launched a handheld Doppler ultrasound device for bedside assessment of peripheral blood flow, aiding in early detection of gangrene risk factors.


    Philips Healthcare Introduced a next-generation angiography system with improved image resolution and faster scan times, facilitating detailed vascular visualization for diagnosing gangrene-related blockages.


    Masimo Developed a wearable pulse oximeter with advanced sensors for monitoring tissue oxygen levels in diabetic foot ulcers, potentially helping prevent gangrene progression.


    Nonin Medical Collaborated with a university research team to investigate the use of bioimpedance spectroscopy for non-invasive assessment of tissue viability and early detection of gangrene.


    List of Gangrene Key companies in the market



    • MediPurpose Private Limited (US),

    • Baril Corporation (US),

    • McKesson Corporation,

    • Cardinal Health (Dublin),

    • Advanced Tissue (US),

    • TRIAGE MEDITECH PVT. LTD. (India),

    • Integra LifeSciences Corporation (US),

    • Covalon Technologies Ltd. (Canada),

    • Advanced Medical Solutions Group plc (UK)